Campbell & Co Investment Adviser’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Buy |
+50,392
| New | +$556K | 0.04% | 749 |
|
|
2024
Q3 | – | Sell |
-44,180
| Closed | -$375K | – | 1322 |
|
|
2024
Q2 | $375K | Buy |
44,180
+28,678
| +185% | +$243K | 0.03% | 756 |
|
|
2024
Q1 | $139K | Buy |
+15,502
| New | +$139K | 0.01% | 1045 |
|
|
2022
Q2 | – | Sell |
-25,100
| Closed | -$240K | – | 911 |
|
|
2022
Q1 | $240K | Buy |
+25,100
| New | +$240K | 0.06% | 562 |
|
|
2021
Q4 | – | Sell |
-27,200
| Closed | -$201K | – | 815 |
|
|
2021
Q3 | $201K | Buy |
+27,200
| New | +$201K | 0.07% | 523 |
|
|
2020
Q1 | – | Sell |
-8,928
| Closed | -$231K | – | 469 |
|
|
2019
Q4 | $231K | Buy |
+8,928
| New | +$231K | 0.07% | 527 |
|